Showing results (1-10 of 51) with videos related to
Sort By:
Pageof 6
Glycoconjugate Journal|May 1, 2012
Galectins and their ligands: negative regulators of anti-tumor immunityFiliberto Cedeno-Laurent, Charles J DimitroffClinical Immunology (Orlando, Fla.)|October 25, 2011
Galectin-1 research in T cell immunity: past, present and futureFiliberto Cedeno-Laurent, Charles J DimitroffJournal of Immunology (Baltimore, Md. : 1950)|February 21, 2012
Galectin-1 triggers an immunoregulatory signature in Th cells functionally defined by IL-10 expressionFiliberto Cedeno-Laurent, Matthew Opperman, Steven R Barthel, et al.Blood|March 3, 2012
Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphomaFiliberto Cedeno-Laurent, Rei Watanabe, Jessica E Teague, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 17, 2010
Development of a nascent galectin-1 chimeric molecule for studying the role of leukocyte galectin-1 ligands and immune disease modulationFiliberto Cedeno-Laurent, Steven R Barthel, Matthew J Opperman, et al.The Journal of Biological Chemistry|April 16, 2011
Peracetylated 4-fluoro-glucosamine reduces the content and repertoire of N- and O-glycans without direct incorporationSteven R Barthel, Aristotelis Antonopoulos, Filiberto Cedeno-Laurent, et al.The Journal of Investigative Dermatology|December 14, 2011
Metabolic inhibition of galectin-1-binding carbohydrates accentuates antitumor immunityFiliberto Cedeno-Laurent, Matthew J Opperman, Steven R Barthel, et al.Cancer Research|July 31, 2015
Galectin-Binding O-Glycosylations as Regulators of MalignancyCharles J DimitroffCurrent Opinion in Immunology|December 11, 2012
Leveraging fluorinated glucosamine action to boost antitumor immunityCharles J DimitroffProceedings of the National Academy of Sciences of the United States of America|June 20, 2019
I-branched carbohydrates as emerging effectors of malignant progressionCharles J DimitroffPageof 6